Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Growth hormone deficiency

Not recruiting

Registered drugNo placebo

Study on Growth Hormone Deficiency: Comparing Effects of Continuing vs. Stopping Somatropin Treatment in Pubertal Children with Isolated Growth Hormone Deficiency

Registered drugNo placebo

Austria

Participants:0–17 years
Substances:Somatropin

Contact Research Centre

Anti-glomerular basement membrane disease

Not recruiting

Registered drugNo placebo

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Retinitis pigmentosa

Not recruiting

Registered drug

Study on the Effects of Oral N-Acetylcysteine for Patients with Retinitis Pigmentosa

Registered drug

Austria

Participants:18–64 years
Substances:Acetylcysteine

Contact Research Centre

Macular oedema

Not recruiting

InvestigationalNo placebo

Study on the Effects of RO7200220 for Adults and Children with Uveitic Macular Edema

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Humanised Igg2 Monoclonal Antibody Against Interleukin-6

Contact Research Centre

Heart failure with reduced ejection fraction

Not recruiting

Investigational

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Vericiguat

Contact Research Centre

Find therapies in clinical trials near you – page 32

411 trials match your criteria

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Follicular lymphoma+1

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Breast cancer+2

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Prophylaxis against transplant rejection

Study on Tacrolimus Dosing for Stable Adult Kidney Transplant Patients in the First Year After Transplantation

Squamous cell carcinoma of head and neck

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Hepatitis D

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Pulmonary hypertension

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Growth hormone deficiency

Study on Growth Hormone Deficiency: Comparing Effects of Continuing vs. Stopping Somatropin Treatment in Pubertal Children with Isolated Growth Hormone Deficiency

Anti-glomerular basement membrane disease

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Retinitis pigmentosa

Study on the Effects of Oral N-Acetylcysteine for Patients with Retinitis Pigmentosa

Macular oedema

Study on the Effects of RO7200220 for Adults and Children with Uveitic Macular Edema

Heart failure with reduced ejection fraction

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.